Effects of Combination Exercise on Fatigability in Veterans With Chronic Kidney Disease

Objective and Subjective Measures of Fatigability in Veterans With Chronic Kidney Disease Before and After Flywheel Resistance Plus Aerobic Exercise

The VA health care system uses a health promotion-focused model which aims to provide longitudinal care through a patient-aligned care team for Veterans with chronic kidney disease. Since the largest subpopulation of Veterans with chronic kidney disease is comprised of those not requiring dialysis, neuromuscular screening assessments may provide valuable information regarding an individual overall health status and potential for future complications. Furthermore, identifying at risk individuals early in the disease process will allow for the prescription of timely interventions. Exercise strategies such as combination exercise, which uses flywheel resistance plus aerobic exercise, may provide a valuable treatment option for combating neuromuscular dysfunction and functional decline in patients with chronic kidney disease.

Study Overview

• Status: Recruiting
• Conditions: Chronic Kidney Disease Predialysis
• Intervention / Treatment: Behavioral: Combination Exercise

Detailed Description

Chronic kidney disease (CKD) is a complex medical condition affecting as much as 36% of the Veteran population. Both empirical and anecdotal evidence identify elevations in fatigability as a major health concern in Veterans with CKD predialysis. Neuromuscular deteriorations resulting from CKD are likely to contribute to excessive fatigability, impacting an individual's functional status. Flywheel resistance exercise (FRE) uses inertial resistance to allow for optimal muscle loading through the entire concentric muscle action and promotes greater eccentric force generation compared to traditional resistance exercise. FRE has been shown to be superior to traditional resistance exercise for improving muscle strength, power, and physical function in healthy populations suggesting it may be a useful treatment for addressing neuromuscular impairments and functional decline. However, it is unclear if the addition of aerobic exercise to FRE would provide additive improvements in fatigue resistance in patients with CKD, without compromising neuromuscular and functional benefits. The purpose of this project is to (1) advance the understanding of performance fatigability and perceived fatigability, and the association with neuromuscular capacity in Veterans with CKD stage 3 & 4 predialysis and (2) determine the extent to which combination FRE plus aerobic exercise training can improve fatigability status, neuromuscular capacity, and physical function in Veterans with CKD stage 3 & 4 predialysis. The central hypothesis is that reductions in neuromuscular capacity are associated with increases in fatigability severity, and that FRE plus aerobic exercise training will reduce fatigability severity while enhancing neuromuscular and functional capabilities in Veterans with CKD stage 3 & 4 predialysis. To address this hypothesis, researchers will characterize performance fatigability and perceived fatigability, and assess the associations between fatigability outcomes and neuromuscular capacity in Veterans with CKD stage 3 & 4 predialysis and examine the effects of 12-weeks of FRE plus aerobic exercise training on changes in performance and perceived fatigability, neuromuscular capacity, and physical function in Veterans with CKD stage 3 & 4 predialysis. Findings from this project will provide valuable information for advancing the understanding of performance fatigability and perceived fatigability, and their inter-relationship, in Veterans with CKD stages 3 and 4. Additionally, novel evidence on the responsiveness of performance and perceived fatigability, neuromuscular capacity, and quality of life to FRE plus aerobic exercise training will be gained.

• Study Type: Interventional
• Enrollment (Anticipated): 30
• Phase: Phase 2

Contacts and Locations

• Study Contact: Name: Jared M Gollie, PhD; Phone Number: (202) 745-8000; Email: Jared.Gollie@va.gov

Study Locations

• United States
  • District of Columbia
    • Washington, District of Columbia, United States, 20422-0001
      • Recruiting
      • Washington DC VA Medical Center, Washington, DC
      • Contact: Jared M Gollie, PhD; Phone Number: 202-745-8000; Email: Jared.Gollie@va.gov
      • Principal Investigator: Jared M. Gollie, PhD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 50 years to 85 years (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Ambulatory (with or without a gait aid), 50 years of age or older diagnosed with chronic kidney disease (CKD) stages 3 & 4 predialysis (as defined by eGFR 59-15 ml/min per 1.73m2)
• Control group will include ambulatory individuals without clinical evidence of kidney disease (defined by eGRF >60 ml/min per 1.73m2) within the last 12-months
• All participants must be able to speak and read English, and demonstrate orientation to person, place, and time

Exclusion Criteria:

• adults diagnosed with acute renal failure/injury within the last 12-months
• non-ambulatory individuals
• adults who do not use the DC VAMC as their main site for renal care
• those who have any uncontrolled cardiovascular
• musculoskeletal disease
• or other conditions that, in the opinion of the principal investigator, could make participation in the study unsafe
• any orthopedic or joint pain which would prevent the participant from safely engaging in the study protocol
• additionally, individuals with plans to relocate from the DC metro area within one year will not be eligible for the intervention portion of the study

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Combination Exercise; Flywheel resistance exercise plus aerobic exercise	Behavioral: Combination Exercise; Flywheel Resistance Plus Aerobic Exercise; Other Names: Flywheel Resistance Plus Aerobic Exercise
No Intervention: Standard-of-care; Participants will maintain standard-of-care and current activity levels during the course of the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
change in knee extensor fatigability	Knee extensor fatigability will be assessed as changes in torque of the dominant leg during 30 contractions.	week 6 and 12
change in perceived fatigability	Rating of perceived fatigability will be assessed using a 10-point scale with 0 indicating "not fatigued at all" and 10 indicating "absolutely exhausted". Low scores reflect lower perceived fatigability.	week 6 and 12
change in muscle blood flow	Muscle blood flow of the vastus lateralis will be assessed using near-infrared spectroscopy and determined as the change in total hemoglobin during venous occlusion test.	week 6 and 12

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
change in muscle Quality	Muscle quality of the vastus lateralis will be assessed using diagnostic ultrasound and determined using grayscale analysis.	week 12
change in Sit-to-Stand	Sit-to-stand test will be used to assess physical function and determined as the time taken to complete five sit-to-stand repetitions.	week 12
change in rate of torque development	Rate of torque development will be calculated as the change in torque over the change in time during isometric knee extensions.	week 12

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
change in muscle activation	Muscle activation of the vastus lateralis will be determined using electromyography as the root mean square during isometric knee extensions.	week 12
change in interleukin 6 (IL-6) and tumor necrosis factor alpha	Interleukin 6 (IL-6) (pg/ml) and tumor necrosis factor alpha (pg/ml) will be assessed from blood samples.	week 12
change in health-related quality of life	Health-related quality of life will be assessed using the Short-form 36	week 12
change in high density c-reactive protein	Change in high density c-reactive protein (mg/L) will be assessed from blood samples.	week 12

Collaborators and Investigators

• Sponsor: VA Office of Research and Development
• Investigators: Principal Investigator: Jared M. Gollie, PhD, Washington DC VA Medical Center, Washington, DC

Study record dates

Study Major Dates

• Study Start (Actual): June 1, 2022
• Primary Completion (Anticipated): April 1, 2026
• Study Completion (Anticipated): April 1, 2026

Study Registration Dates

• First Submitted: May 13, 2020
• First Submitted That Met QC Criteria: May 19, 2020
• First Posted (Actual): May 21, 2020

Study Record Updates

• Last Update Posted (Actual): May 17, 2023
• Last Update Submitted That Met QC Criteria: May 16, 2023
• Last Verified: May 1, 2023

More Information

Terms related to this study

• Keywords: rehabilitation; strength; eccentric exercise; fatigability; combination exercise
• Additional Relevant MeSH Terms: Urologic Diseases; Renal Insufficiency; Kidney Diseases; Renal Insufficiency, Chronic
• Other Study ID Numbers: F3423-W

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No